Tart Cherry: Sleep, Exercise Recovery and Preparation Differences

What is tart cherry?

Tart or sour cherry is Prunus cerasus. Montmorency is a variety used in supplement research. Products include ready-to-drink juice, concentrated juice and dried fruit or skin powders. People take them for sleep, exercise recovery and joint or gout symptoms.

Traditional food and household uses predate these supplement studies, but they do not identify an effective dose. Modern research measures separate outcomes: sleep duration, waking during the night, muscle soreness, strength recovery, serum urate and knee pain. A result for one does not answer the others.

Older uses and today's research

Sour cherries have long been eaten and prepared as juice and preserves. Cherry products have also been used informally for gout and joint discomfort. The published gout literature describes that use as largely anecdotal before controlled testing. Claims that ancient traditions established a sleep treatment or that a particular Unani remedy used today's Montmorency concentrate need more specific historical evidence. ^[1]

Why do people take tart cherry?

The exercise studies mainly involve demanding sessions, races or closely spaced events. They do not tell us much about using tart cherry during an ordinary training week.

How should you compare labels?

Start with the preparation and serving instructions. Ready-to-drink juice is measured as the beverage you drink; concentrate is measured before dilution. Adding water increases beverage volume without increasing the amount of concentrate.

For powders and capsules, identify whether the ingredient is whole fruit, skin or an extract. The 480 mg powder used in several exercise studies was a particular freeze-dried Montmorency skin preparation. That number is not a universal dose for all cherry capsules, and the exercise studies do not supply a capsule dose for insomnia.

Check the amount per full daily serving, sugar and other active ingredients. Some research on sleep products combines cherry with additional ingredients, so a favorable result for the mixture cannot identify cherry's individual contribution. “Equivalent to hundreds of cherries” also leaves out processing and composition. Measured anthocyanins—plant pigments found in cherries—describe composition, but do not by themselves establish how much sleep benefit to expect.

What are the drawbacks?

NIH ODS^[2] describes short studies using roughly half a U.S. quart of juice daily—about 473 mL—or 480 mg/day of freeze-dried skin powder without identified safety concerns.

Juice and concentrate can add substantial sugar or calories, depending on the product; compare the daily amount on its Nutrition Facts label. The osteoarthritis trial reported one participant with elevated blood glucose after the cherry-juice period. The available studies do not establish that tart cherry changes the effect of blood thinners, diuretics or anti-inflammatory medicines, so we would not print a general interaction rule for those drugs. If a clinician is treating gout or arthritis, bring the exact product to that discussion. Whether long-term use changes training adaptation has not been tested well enough to treat it as a known drawback.

If poor sleep persists, assessment of the cause matters. In one cherry-juice insomnia pilot, sleep testing identified sleep apnea in three of eleven randomized participants; they were excluded from the analysis and referred for care.

What do the studies show?

Small studies suggest tart cherry can improve selected sleep measurements, but the results depend on who was studied and how sleep was measured.

Sleep diaries: fewer minutes awake, without a clear improvement in every measure

In Pigeon and colleagues' 2010 pilot^[3], fifteen older adults with insomnia tried a proprietary cherry-juice blend and placebo in a crossover study: each person tried both drinks in separate two-week periods. Participants recorded their sleep and completed an insomnia questionnaire.

The juice improved insomnia severity and time awake after initially falling asleep. Total sleep time, the time needed to fall asleep and the proportion of time in bed spent asleep did not differ significantly between treatments. Improvements from the participants' own starting values were broader, which is why the placebo comparison matters here.

CherryPharm, the juice maker, funded the study. Its results support a small improvement in waking during the night in this small older group.

Wrist monitoring: a favorable short study in healthy adults

The 2012 Howatson study^[4] involved twenty healthy adults in a seven-day crossover trial. A wrist activity monitor estimated more total sleep, more time in bed and better sleep efficiency—the proportion of time in bed spent asleep—with concentrate than placebo. Urinary melatonin also increased, while the timing of its daily rhythm did not differ significantly.

CherryActive donated the concentrate. These were healthy volunteers rather than people selected for chronic insomnia, and the trial lasted only one week.

Overnight sleep testing: an intriguing result from eight people

Losso and colleagues' pilot^[5] randomized eleven adults aged over fifty with insomnia. Eight completed both two-week conditions after three participants with sleep apnea were excluded. Overnight laboratory monitoring found 84 minutes more sleep with juice than placebo.

That large difference came from eight analyzed participants. Laboratory-measured sleep efficiency, time to fall asleep and waking after sleep onset did not improve significantly. A questionnaire component about habitual sleep efficiency improved, but insomnia severity and daytime sleepiness questionnaires did not. Thus, the positive objective result was sleep duration; “better sleep” across all measures would overstate it.

The Cherry Marketing Institute supplied the juice and supported the trial; the authors said it had no role in the design. NIH grants also supported the work. The small sample and brief observation make the size and durability of the effect uncertain.

Amounts and duration in the studies

Howatson used 30 mL of CherryActive concentrate twice daily for seven days, diluted in about 200 mL water per serving, shortly after waking and before the evening meal. Losso used 240 mL of juice twice daily for two weeks, in the morning and one to two hours before bed.

Does it help exercise recovery?

Some small trials found better recovery after demanding exercise. The clearest way to read them is to keep the strength tests beside the soreness reports.

Better recovery after intense intermittent exercise

A 2016 trial by Bell and colleagues^[6] assigned sixteen semi-professional male soccer players to concentrate or a calorie-matched placebo. They used 30 mL twice daily for eight days, with a demanding shuttle-running protocol on day five.

During the following three days, several recovery measures favored cherry: soreness was lower, strength was better preserved, and some jump, sprint and agility measurements recovered more favorably. Sprint times during the exercise protocol itself did not differ significantly. Several blood markers also had null results, despite a lower response in one inflammatory marker. This trial is most directly relevant to recovery after an intense intermittent effort.

No clear overall strength benefit after a squat workout

The 2015 Levers trial^[7] studied 23 resistance-trained men who completed a demanding squat protocol. They took 480 mg/day of CherryPURE skin powder or rice-flour placebo for ten days, beginning seven days before exercise.

One thigh measurement site showed a favorable soreness pattern, while the overall soreness comparison was not significant. Tests of knee extension, knee flexion and total work did not show significant differences in how the groups changed over recovery. The authors' favorable summary about strength recovery is broader than these overall test results.

Anderson Global Group and Shoreline Fruit funded the study; one author disclosed consulting for Anderson Global Group. This is a useful counterweight to the impression that every recovery study found stronger muscles and less soreness throughout recovery.

Blood-marker changes without faster cycling

In Bell's 2014 cycling trial^[8], sixteen trained cyclists used 30 mL concentrate or placebo twice daily for seven days. They completed simulated road-racing sessions on three consecutive days. Cherry reduced the responses of certain inflammatory and oxidative-stress markers; other markers did not differ significantly.

The repeated-day setting is relevant to closely spaced competitions. The favorable findings were blood measurements. Declines in time-trial performance did not differ between groups, so reduced inflammatory markers did not translate into a demonstrated performance advantage.

Can tart cherry improve endurance performance?

There is a notable positive half-marathon result, alongside insufficient overall evidence for a reliable performance benefit.

In the 2016 Levers trial^[9], 27 trained runners and triathletes completed a half-marathon after taking 480 mg/day of skin powder or placebo. Eleven powder users finished in about 103 minutes, compared with 118 minutes among sixteen placebo users. The researchers described this as a 13% faster finish.

Although the cherry group finished faster, it did not clearly outperform its expected pace more than the placebo group did. That makes the apparent race-time advantage less convincing. It was a small parallel-group study, rather than the same runners racing under both conditions. Soreness was already lower at one site before the run, complicating the recovery comparison. Anderson Global Group and Shoreline Fruit funded this study too.

NIH ODS^[2] discusses this favorable trial while still judging aerobic-performance evidence insufficient and noting the lack of expert consensus for athletes to use tart cherry.

What about gout and osteoarthritis?

Gout attacks and serum urate

In a case-crossover study of 633 people with gout^[10], cherry intake during the two days before an attack was associated with a 35% lower attack risk than periods without cherry intake. This compared different periods in the same people, but it was observational, included cherries and cherry extract rather than one standardized tart-cherry supplement.

The intervention results disagree. A 26-person crossover trial^[1] in overweight adults found lower serum urate after 240 mL of tart-cherry juice daily for four weeks than after a placebo drink. Those participants were not selected for gout. In a 28-day randomized trial in people with gout^[11], concentrate at 7.5–30 mL twice daily did not significantly improve serum urate, urinary urate excretion or flare frequency compared with placebo.

Knee osteoarthritis

A 58-person crossover trial^[12] tested a tart-cherry juice blend against placebo in people with knee osteoarthritis. Participants drank two 8 oz bottles daily for six weeks, then switched after a washout. The pain-and-function score improved compared with the group's own starting point during cherry use, but the difference between cherry and placebo was not statistically clear. A blood inflammation marker fell more with cherry; that did not establish better symptom relief. The study does not support a claim that tart cherry treats knee osteoarthritis pain.

The bottom line

For sleep

Small studies suggest that some juice or concentrate preparations can increase measured sleep time or reduce waking, but they disagree across sleep measures and involved short courses.

For training

Some studies found better recovery after unusually hard exercise; others did not find better strength or performance. A short, targeted trial around demanding events is closer to the research than indefinite daily use. Compare the full serving, sugar and cost before deciding whether the possible benefit matters to you.

For gout and knee osteoarthritis, the studies do not yet show dependable clinical benefit. Cherry intake's association with fewer gout attacks is interesting, while the concentrate trial in people with gout and the placebo comparison for knee symptoms were negative.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly